SMS Pharmaceuticals - Quaterly Results

05 Aug 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 1644.51 millions grew by 21.51 % from Rs. 1353.39 millions.Handsome Net Profit growth of 75.91% reported above the corresponding previous quarter figure of Rs. 163.28 millions to Rs. 92.82 millions.Operating profit for the quarter ended June 2024 rose to 348.33 millions as compared to 271.70 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1644.51 1353.39 21.51 1644.51 1353.39 21.51 7092.63 5220.51 35.86
Other Income 13.68 5.13 166.67 13.68 5.13 166.67 44.60 49.14 -9.24
PBIDT 348.33 271.70 28.20 348.33 271.70 28.20 1213.04 595.88 103.57
Interest 46.67 63.23 -26.19 46.67 63.23 -26.19 234.57 219.13 7.05
PBDT 301.66 208.47 44.70 301.66 208.47 44.70 978.47 376.75 159.71
Depreciation 83.82 76.91 8.98 83.82 76.91 8.98 315.16 321.25 -1.90
PBT 217.84 131.56 65.58 217.84 131.56 65.58 663.31 55.50 1095.15
TAX 54.56 38.74 40.84 54.56 38.74 40.84 169.07 14.65 1054.06
Deferred Tax 1.56 4.74 -67.09 1.56 4.74 -67.09 17.79 14.69 21.10
PAT 163.28 92.82 75.91 163.28 92.82 75.91 494.24 40.85 1109.89
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 21.18 20.08 5.51 21.18 20.08 5.51 17.10 11.41 49.84

SMS Pharmaceuticals Share Price

214.35 10.70 (5.25%)
21-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1643.05
Dr. Reddys Lab 1151.95
Cipla 1474.30
Lupin 1906.15
Zydus Lifesciences 885.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on